These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 7060018)
1. Mutagenic and alkylating activities of 3-methyl-1-phenyltriazenes and their possible role as carcinogenic metabolites of the parent dimethyl compounds. Malaveille C; Brun G; Kolar G; Bartsch H Cancer Res; 1982 Apr; 42(4):1446-53. PubMed ID: 7060018 [TBL] [Abstract][Full Text] [Related]
2. Unexpected genetic toxicity to rodents of the N',N'-dimethyl analogues of MNU and ENU. Tinwell H; Paton D; Guttenplan JB; Ashby J Environ Mol Mutagen; 1996; 27(3):202-10. PubMed ID: 8625956 [TBL] [Abstract][Full Text] [Related]
3. Quantitative comparisons between carcinogenicity, mutagenicity and electrophilicity of direct-acting N-nitroso compounds and other alkylating agents. Bartsch H; Malaveille C; Tomatis L; Brun G; Dodet B; Terracini B IARC Sci Publ; 1982; (41):525-32. PubMed ID: 6754595 [TBL] [Abstract][Full Text] [Related]
4. Biological and chemical properties of alkanediazotates as active species of N-nitroso compounds. Ukawa S; Mochizuki M IARC Sci Publ; 1991; (105):404-6. PubMed ID: 1855889 [TBL] [Abstract][Full Text] [Related]
5. Mutagenic properties of allylic and alpha, beta-unsaturated compounds: consideration of alkylating mechanisms. Eder E; Henschler D; Neudecker T Xenobiotica; 1982 Dec; 12(12):831-48. PubMed ID: 6763406 [TBL] [Abstract][Full Text] [Related]
6. Comparative carcinogenicity of ring-halogenated 3-methyl-1-phenyltriazenes and their 3,3-dimethyl analogs at equimolar dose levels in male Sprague-Dawley rats. Berger MR; Kolar GF J Cancer Res Clin Oncol; 1986; 111(2):129-32. PubMed ID: 3700457 [TBL] [Abstract][Full Text] [Related]
7. Rat and mouse tissue-mediated mutagenicity of ring-substituted 3,3-dimethyl-1-phenyltriazenes in Salmonella typhimurium. Malaveille C; Kolar GF; Bartsch H Mutat Res; 1976 Jul; 36(1):1-10. PubMed ID: 7749 [TBL] [Abstract][Full Text] [Related]
8. Comparative metabolism and carcinogenicity of ring-halogenated 3,3-dimethyl-1-phenyltriazenes. Kolar GF; Habs M J Cancer Res Clin Oncol; 1984; 108(1):71-5. PubMed ID: 6746720 [TBL] [Abstract][Full Text] [Related]
9. Mutagenicity of dimethyl heteroaromatic triazenes in the Ames test: the role of hydrophobicity and electronic effects. Shusterman AJ; Debnath AK; Hansch C; Horn GW; Fronczek FR; Greene AC; Watkins SF Mol Pharmacol; 1989 Dec; 36(6):939-44. PubMed ID: 2601689 [TBL] [Abstract][Full Text] [Related]
10. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents. Schmid FA; Otter GM; Mehta BM Cancer Res; 1985 Jan; 45(1):40-4. PubMed ID: 3965147 [TBL] [Abstract][Full Text] [Related]
11. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6). Ress NB; Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695 [TBL] [Abstract][Full Text] [Related]
12. Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compounds. Wood AW; Levin W; Chang RL; Huang MT; Ryan DE; Thomas PE; Lehr RE; Kumar S; Koreeda M; Akagi H; Ittah Y; Dansette P; Yagi H; Jerina DM; Conney AH Cancer Res; 1980 Mar; 40(3):642-9. PubMed ID: 7471084 [TBL] [Abstract][Full Text] [Related]
13. Mutagenic activity of the dacarbazine analog p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt in bacterial cells. Tamaro M; Dolzani L; Monti-Bragadin C; Sava G Pharmacol Res Commun; 1986 May; 18(5):491-501. PubMed ID: 3526359 [TBL] [Abstract][Full Text] [Related]
14. Mutagenicity and anti-mutagenicity of selected spices. Soudamini KK; Unnikrishnan MC; Sukumaran K; Kuttan R Indian J Physiol Pharmacol; 1995 Oct; 39(4):347-53. PubMed ID: 8582746 [TBL] [Abstract][Full Text] [Related]
16. Genotoxicity profiles of common alkyl halides and esters with alkylating activity. Sobol Z; Engel ME; Rubitski E; Ku WW; Aubrecht J; Schiestl RH Mutat Res; 2007 Oct; 633(2):80-94. PubMed ID: 17644026 [TBL] [Abstract][Full Text] [Related]
17. Oxidative metabolism of 1-(2-chloroethyl)-3-alkyl-3- (methylcarbamoyl)triazenes: formation of chloroacetaldehyde and relevance to biological activity. Rouzer CA; Sabourin M; Skinner TL; Thompson EJ; Wood TO; Chmurny GN; Klose JR; Roman JM; Smith RH; Michejda CJ Chem Res Toxicol; 1996; 9(1):172-8. PubMed ID: 8924588 [TBL] [Abstract][Full Text] [Related]
18. [Genotoxic effects of metabolic derivatives of the new drug phosphabenzide]. Il'inskaia ON; Ivanchenko OB; Trubnikova GG; Valimukhametova DA; Tarasova RI; Bagautdinova DB Genetika; 1998 Feb; 34(2):308-12. PubMed ID: 9589859 [TBL] [Abstract][Full Text] [Related]
19. Contamination is a frequent confounding factor in toxicology studies with anthraquinone and related compounds. Butterworth BE; Mathre OB; Ballinger KE; Adalsteinsson O Int J Toxicol; 2004; 23(5):335-44. PubMed ID: 15513832 [TBL] [Abstract][Full Text] [Related]
20. Mutagenicity of N-methyl-N'-aryl-N-nitrosoureas and N-methyl-N'-aryl-N'-methyl-N-nitrosoureas in relation to their alkylating activity. Yano K; Isobe M Cancer Res; 1979 Dec; 39(12):5147-9. PubMed ID: 387220 [No Abstract] [Full Text] [Related] [Next] [New Search]